Taclonex

Product manufactured by Leo Pharma Inc.

Application Nr Approved Date Route Status External Links
NDA022185 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Taclonex ® Topical Suspension Is Indicated For The Topical Treatment Of Plaque Psoriasis Of The Scalp And Body In Patients 12 Years And Older. Taclonex Topical Suspension Is A Combination Of Calcipotriene, A Vitamin D Analog, And Betamethasone Dipropionate, A Corticosteroid, Indicated For The Topical Treatment Of Plaque Psoriasis Of The Scalp And Body In Patients 12 Years And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments